Cholera: Clinical Trials

8 trials for Cholera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 unknown. 8 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Recruiting 1, Unknown 1
Phase 22Completed 2

Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers
PanChol - Cholera Vaccination Reaction
Phase 1RecruitingCentre for Infectious Disease Research in Zambia322026-05-202026-10-06
First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers
PanChol - Cholera, Cholera Vaccine Toxicity
Phase 1UnknownBrigham and Women's Hospital532022-12-122022-12-20
Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine
HL-OCV, Shanchol - Cholera
Phase 1 / Phase 2CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh8402016-07-012018-11-02
PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera
iOWH032 - Diarrhea, Cholera
Phase 1CompletedPATH262013-05-012015-06-11
To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men
Euvichol - Prevention Harmful Effects
Phase 1CompletedEuBiologics Co.,Ltd202012-09-012013-02-20
Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200
PXVX0200, Placebo - Cholera
Phase 1CompletedBavarian Nordic662012-04-012023-06-27
Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects
Ciprofloxacin, Peru-15-pCTB, Sodium bicarbonate/Ascorbic Acid/Aspartame Buffer - Gastroenteritis Escherichia Coli
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)622008-06-022021-07-29
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
Placebo, Control, Zinc Sulphate - Cholera, Typhoid
Phase 1 / Phase 2CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh10162008-02-012011-07-12

Narrower conditions

Diarrhea (2)  ·  Escherichia coli Infections (1)  ·  Typhoid Fever (1)

Broader conditions

Bacterial Infections (8)  ·  Bacterial Infections and Mycoses (8)  ·  Gram-Negative Bacterial Infections (8)  ·  Infections (8)  ·  Vibrio Infections (8)  ·  Enterobacteriaceae Infections (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Salmonella Infections (1)

Interventions

Albendazole (1)  ·  Arsenic (1)  ·  Ciprofloxacin (1)  ·  IOWH-032 (1)  ·  Sodium Bicarbonate (1)  ·  Zinc Sulfate (1)  ·  secnidazole (1)  ·  shanchol (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (2)  ·  Bavarian Nordic (1)  ·  Brigham and Women's Hospital (1)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  EuBiologics Co.,Ltd (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  PATH (1)

Countries

Bangladesh (3)  ·  United States (3)  ·  South Korea (1)  ·  Zambia (1)

Top investigators

Firdausi Qadri, Dr. (1)  ·  Firdausi Qadri, PhD (1)  ·  Hong J Hee, Ph.D (1)  ·  Mohammed A Salam, MBBS (1)

Results publications

PMID 16760521, PMID 18398491, PMID 22461716, PMID 24173028, PMID 24753695, PMID 25410205, PMID 34218960, PMID 41519137